WEIGHT LOSS OF ≥3% IN TYPE II DIABETES PATIENTS IS ASSOCIATED WITH WEIGHT CHANGE PROPERTY OF NEWLY PRESCRIBED ANTI-DIABETIC MEDICINE IN ANTI-DEPRESSANT USERS OVER A 12-MONTH FOLLOW-UP PERIOD

被引：1

作者：

Lin, C. C. ^{[1
]}

Mukherjee, J. ^{[2
]}

Kawabata, H. ^{[3
]}

Colilla, S. ^{[3
]}

Wygant, G. ^{[4
]}

机构：

[1] Univ N Carolina, Chapel Hill, NC USA

[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA

[3] Bristol Myers Squibb, Hopewell, NJ USA

[4] Bristol Myers Squibb Co, Princeton, NJ USA

来源：

关键词：

D O I：

10.1016/j.jval.2013.08.625

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A431 / A431

页数：1

共 2 条